<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03339128</url>
  </required_header>
  <id_info>
    <org_study_id>3030-202-002</org_study_id>
    <secondary_id>2017-003770-14</secondary_id>
    <nct_id>NCT03339128</nct_id>
  </id_info>
  <brief_title>Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.</brief_title>
  <official_title>A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Evaluate the Safety and Efficacy of Eluxadoline in Pediatric Patients (Age 12 to 17 Years) With Irritable Bowel Syndrome With Diarrhea (IBS-D)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Allergan</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Allergan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objectives of this study are to explore the therapeutic effect of eluxadoline in
      treating IBS-D in pediatric patients 12-17 years of age, to evaluate the pharmacokinetics of
      eluxadoline in pediatric patients with IBS-D, and to evaluate the safety and tolerability of
      eluxadoline in pediatric patients with IBS-D.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 15, 2017</start_date>
  <completion_date type="Anticipated">February 6, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2023</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in stool consistency averaged over the 4-week Treatment Period</measure>
    <time_frame>Baseline (2 Weeks prior to randomization) to Week 4</time_frame>
    <description>Stool consistency will be assessed using the Pediatric Bristol Stool Form Scale (p-BSFS) on a range from 1 (Hard Lumps) to 7 (Watery).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in stool consistency for daily daytime and nighttime stool consistency scores</measure>
    <time_frame>Baseline (2 Weeks prior to randomization) to Week 4</time_frame>
    <description>Stool consistency will be assessed using the Pediatric Bristol Stool Form Scale (p-BSFS) on a range from 1 (Hard Lumps) to 7 (Watery).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline for daytime, nighttime, and 24-hour abdominal pain scores</measure>
    <time_frame>Baseline (2 Weeks prior to randomization) to Week 4</time_frame>
    <description>Abdominal Pain is scored on a five-point ordinal scale, with 0 meaning no pain, and 4 meaning a lot of pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline for daytime, nighttime, and 24-hour bowel movement frequency</measure>
    <time_frame>Baseline (2 Weeks prior to randomization) to Week 4</time_frame>
    <description>Change from baseline in the number of bowel movements.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline for daytime, nighttime, and 24 hour urgency-free days</measure>
    <time_frame>Baseline (2 Weeks prior to randomization) to Week 4</time_frame>
    <description>Change from baseline in the number urgency free days in a week.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline for daytime, nighttime, and 24 hour number of fecal incontinence-free days</measure>
    <time_frame>Baseline (2 Weeks prior to randomization) to Week 4</time_frame>
    <description>Change from baseline in the number of fecal incontinence-free days in a week.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Irritable Bowel Syndrome</condition>
  <arm_group>
    <arm_group_label>Eluxadoline 25mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eluxadoline 25mg, oral administration, twice daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Eluxadoline 50mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eluxadoline 50mg, oral administration, twice daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Eluxadoline 100mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eluxadoline 100mg, oral administration, twice daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dose-matched placebo, oral administration, twice daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Eluxadoline</intervention_name>
    <description>Oral tablets</description>
    <arm_group_label>Eluxadoline 100mg</arm_group_label>
    <arm_group_label>Eluxadoline 25mg</arm_group_label>
    <arm_group_label>Eluxadoline 50mg</arm_group_label>
    <other_name>Viberzi, Truberzi</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Oral tablets</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient must provide written or verbal informed assent and the parent/guardian/LAR
             must provide written informed consent before the initiation of any study-specific
             procedures.

          -  Patient is a male or female outpatient, 12 to 17 years of age inclusive, at the time
             the patient provides assent for the study and parent/guardian/LAR has provided signed
             consent.

          -  Patient is able to read and understand the assessments in the eDiary.

          -  Female patients of childbearing potential must have a negative serum pregnancy test at
             Visit 1 (screening) and a negative urine pregnancy test at Visit 3 (randomization)
             prior to dosing.

          -  Female patients who have had their first menstrual period and are sexually active must
             agree to use a reliable form of contraception. Reliable contraception is defined as:

               1. Hormonal contraception (eg, oral contraceptive, contraceptive implant, or
                  injectable hormonal contraceptive).

               2. Double-barrier method (eg, condom plus intrauterine device, diaphragm plus
                  spermicide).

          -  Patient has a diagnosis of IBS-D as defined by the modified Rome IV child/adolescent
             criteria*: Must include all of the following:

               1. Abdominal pain at least 4 days per month over at least 2 months associated with
                  one or more of the following:

                    1. Related to defecation

                    2. A change in frequency of stool

                    3. A change in form (appearance) of stool

               2. After appropriate evaluation, the symptoms cannot be fully explained by another
                  medical condition

               3. Patient has predominantly diarrheal stool symptoms defined as Bristol stool types
                  6 or 7 for more than 25% of bowel movements and Bristol stool types 1 or 2 for
                  less than 25% of bowel movements that occur in the absence of laxatives

                    -  All criteria fulfilled for at least 2 months prior to Visit 1 (screening).

          -  Patient has been compliant with the eDiary by completing both the morning and evening
             assessments for at least 8 out of the 14 days immediately preceding Visit 3
             (randomization).

          -  Patient has an average daytime abdominal pain scoreless than or equal to 2.0 over the
             2 weeks prior to randomization.

          -  Patient has at least 1 daytime bowel movement with a consistency of Type 6 or Type 7
             on the pediatric Bristol Stool Form Scale (p-BSFS) on at least 2 days per week during
             the 2 weeks prior to randomization that occurs in the absence of laxatives.

          -  Patient has no clinically significant findings on a physical examination, vital sign
             assessment, electrocardiogram (ECG), and clinical laboratory tests (clinical chemistry
             panel, liver biochemical tests, complete blood count, urine drug screen, urinalysis)
             after providing informed assent and after written consent is obtained, but before
             receiving the first dose of study treatment. (A central laboratory will be used to
             evaluate all urine [except urine pregnancy tests] and blood samples and will utilize
             reference ranges specific to a patient's age and gender. ECGs will be performed and
             electronically transmitted to a central ECG laboratory for analysis by a pediatric
             cardiologist in accordance with the instructions provided by the central ECG
             laboratory. The Investigator will determine if a particular finding is clinically
             significant. [In making this determination, the Investigator will consider whether the
             particular finding could represent a condition that would exclude the patient from the
             study, could represent a safety concern if the patient participates in the study, or
             could confound the study-specific assessments of safety or efficacy.])

        Exclusion Criteria:

          -  Patient has no gallbladder, (ie, agenesis of the gallbladder or cholecystectomy).

          -  Patient has had any of the following surgeries:

               1. Any abdominal surgery within the 3 months prior to Screening; or

               2. A history of major gastric, hepatic, pancreatic, or intestinal surgery.(Note:
                  appendectomy, hemorrhoidectomy, or polypectomy greater than 3 months post-surgery
                  are allowed. For the purposes of this study, laparoscopic surgeries without
                  complication are considered minor and non-exclusionary, provided the condition
                  for which the surgery was performed was not exclusionary.)

          -  Patient has a history of chronic or severe constipation or sequelae from constipation,
             or known or suspected mechanical GI obstruction or pseudo obstruction.

          -  Patient has a history or current diagnosis of constipation with encopresis.

          -  Patient meets the child/adolescent Rome IV criteria of IBS with constipation, IBS with
             constipation and diarrhea (mixed), unspecified IBS, or Patient has a history of
             intestinal obstruction, stricture, toxic megacolon, GI perforation, fecal impaction,
             gastric banding, bariatric surgery, adhesions, ischemic colitis, or impaired
             intestinal circulation.

          -  Patient has a documented history of hepatic impairment as defined by Child-Pugh
             Classification Grade A, B or C

          -  Patient has a history or current diagnosis of inflammatory or immune-mediated lower GI
             disorders including inflammatory bowel disease (eg, Crohn's disease, ulcerative
             colitis, microscopic colitis). Crohn's disease affecting the upper GI tract would also
             be exclusionary.

          -  Patient has celiac disease, or a positive serological test for celiac disease and the
             condition has not been ruled out by endoscopic biopsy.

          -  Patient has any congenital and/or acquired malabsorption syndrome (eg,
             Shwachman-Diamond syndrome).

          -  Patient has a history of a microbiologically documented (ie, stool culture or medical
             history) GI infection within 3 months prior to Screening.

          -  Patient has a known lactose or fructose intolerance that is associated with diarrhea,
             abdominal pain or discomfort, and that could confound assessments in the study.

          -  Patient has a history of diverticulitis within 3 months prior to Screening.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Taryn Weissman, MD</last_name>
    <role>Study Director</role>
    <affiliation>Allergan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Clinical Trials Registry Team</last_name>
    <phone>877-277-8566</phone>
    <email>IR-CTRegistration@allergan.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Of Arizona</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85724</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>HealthStar Research, LLC</name>
      <address>
        <city>Hot Springs</city>
        <state>Arkansas</state>
        <zip>71913</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Applied Research of Arkansas</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>501-954-7822</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kindred Medical Institute for Clinical Trials, LLC</name>
      <address>
        <city>Corona</city>
        <state>California</state>
        <zip>92879</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>951-220-4029</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>VVCRD Clinical Research</name>
      <address>
        <city>Garden Grove</city>
        <state>California</state>
        <zip>92845</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Center for Clinical Trials, LLC</name>
      <address>
        <city>Paramount</city>
        <state>California</state>
        <zip>90723</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Wellness Clinical Research, LLC</name>
      <address>
        <city>Hialeah</city>
        <state>Florida</state>
        <zip>33012</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>786-483-7856</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Neuroscience Solutions Inc dba CNS Healthcare</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32256</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>904-281-5757</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Neuroscience Solutions Inc dba CNS Healthcare</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32256</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Sunrise Research Institute</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33125</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>786-409-6849</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Florida Research Center, Inc</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33174</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>786-536-9009</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nemours Children's Clinic, Orlando</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32827</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Treken Primary Care</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30315</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Children's Center for Digestive Health Care</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>404-503-2279</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sleep Care Research Institute/Global Research Associates</name>
      <address>
        <city>Stockbridge</city>
        <state>Georgia</state>
        <zip>30281</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>770-507-5143</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Center for Children's Digestive Health</name>
      <address>
        <city>Park Ridge</city>
        <state>Illinois</state>
        <zip>60068</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>847-723-7700</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Unity Point Health Pediatric Gastroenterology</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61602</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Riley Hospital for Children</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>317-944-9658</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Michael W. Simon, MD, PSC</name>
      <address>
        <city>Nicholasville</city>
        <state>Kentucky</state>
        <zip>40356</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>859-277-6516</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Willis-Knighton Physician Network</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Certified Research Consultants Virgo-Carter Pediatrics</name>
      <address>
        <city>Silver Spring</city>
        <state>Maryland</state>
        <zip>20910</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>301-275-5571</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Celen Medical Group, Corp</name>
      <address>
        <city>Marlton</city>
        <state>New Jersey</state>
        <zip>08053</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>305-763-2384</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ubmd Ddnc</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14222</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>UH Rainbow Babies &amp; Children's Hospital</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>IPS Research Company</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>405-235-8188</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>St. Christopher's Hospital for Children - Drexel University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19134</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Preferred Primary Care Physicians Inc.</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15236</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>412-650-6156</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Coastal Pediatrics Associates</name>
      <address>
        <city>Mount Pleasant</city>
        <state>South Carolina</state>
        <zip>29464</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Cook Children's Digestive Health</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>78215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>682-885-1713</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Texas Children's Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>832-824-1562</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Envision Clinical Research, LLC</name>
      <address>
        <city>Laredo</city>
        <state>Texas</state>
        <zip>78401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sun Research Institute</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>210-227-1289</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Primary Children's Hospital</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Multicare Health Institute for Research and Innovation</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Medical Center-1-Sevlievo EOOD</name>
      <address>
        <city>Sevlievo</city>
        <state>Gabrovo</state>
        <zip>5400</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Korczowski Bartosz, Gabinet Lekarski</name>
      <address>
        <city>Kozloduy</city>
        <zip>3000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Multiprofile Hospital for Active Treatment &quot;Sveti Georgi&quot; EAD</name>
      <address>
        <city>Plovdiv</city>
        <zip>4002</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Multiprofile Hospital for Active Treatment-Ruse</name>
      <address>
        <city>Ruse</city>
        <zip>7002</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>UMHAT Sveta Marina</name>
      <address>
        <city>Varna</city>
        <zip>9000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Edmonton Clinic Health Academy (ECHA)</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 1C9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Research Institute of Manitoba</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3E RP4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>204-789-3206</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helios Universitätsklinikum Wuppertal</name>
      <address>
        <city>Wuppertal</city>
        <state>NRW</state>
        <zip>42349</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Szent Janos Korhaz Budai Gyermekkórháza</name>
      <address>
        <city>Budapest</city>
        <zip>H-1023</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Soproni Erzsebet Oktato Korhaz es Rehabilitacious Intezet</name>
      <address>
        <city>Sopron</city>
        <zip>H9400</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mentahaz Maganorvosi Kozpont</name>
      <address>
        <city>Székesfehérvár</city>
        <zip>8000</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Academisch Medisch Centrum Universiteit Van Amsterdam</name>
      <address>
        <city>Amsterdam</city>
        <zip>1100DD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Instytut Centrum Zdrowia Matki Polki</name>
      <address>
        <city>Lodz</city>
        <state>Lodzkie</state>
        <zip>93-338</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Copertnicus Podmiot Leczniczy Sp. z o.o.</name>
      <address>
        <city>Gdansk</city>
        <zip>8000</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Specjalistyczny Gabinet Naurologiczny Marta Banach</name>
      <address>
        <city>Krakow</city>
        <zip>30-539</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Korczowski Bartosz, Gabinet Lekarski</name>
      <address>
        <city>Rzeszow</city>
        <zip>35-302</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Children's Memorial Health Institute</name>
      <address>
        <city>Warsaw</city>
        <zip>00-632</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Instytut Pomnik Centrum Zdrowia Dziecka</name>
      <address>
        <city>Warsaw</city>
        <zip>04-730</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Dr. Peset</name>
      <address>
        <city>Valencia</city>
        <zip>46017</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+34 961622389</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Blackpool Victoria Hospital</name>
      <address>
        <city>Blackpool</city>
        <zip>FY3 8NR</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>King's College Hospital</name>
      <address>
        <city>London</city>
        <zip>SE5 9RS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Royal Manchester Children's Hospital</name>
      <address>
        <city>Manchester</city>
        <zip>M13 9WL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Bulgaria</country>
    <country>Canada</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://childibsd.com</url>
    <description>Research study website to register and learn more about this study.</description>
  </link>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>November 8, 2017</study_first_submitted>
  <study_first_submitted_qc>November 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2017</study_first_posted>
  <last_update_submitted>June 11, 2020</last_update_submitted>
  <last_update_submitted_qc>June 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Irritable Bowel Syndrome with Diarrhea</keyword>
  <keyword>IBSD</keyword>
  <keyword>IBS-D</keyword>
  <keyword>Irritable Bowel Syndrome</keyword>
  <keyword>Pediatric</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Diarrhea</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eluxadoline</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

